# Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication

> **NCT01760824** · NA · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 391 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Sequential therapy
- **DRUG:** Quadruple therapy

## Key facts

- **NCT ID:** NCT01760824
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 391 (ACTUAL)
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01760824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01760824, "Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01760824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*